Skip to main content
Log in

The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts

  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

Aseptic loosening is one of the major causes of failure of artificial hip joints, and it can occur for several reasons, including osteolysis of the bone tissue in response to stress shielding or cellular reactions to wear debris. Any treatment of the prosthesis which could minimize the osteolytic response of bone tissue may be able to extend the life-time of the implant. Bisphosphonates are potent inhibitors of osteoclastic bone resorption, and they bind avidly to hydroxyapatite (HA). Coating the prostheses with bisphosphonates may therefore inhibit osteolysis. We have investigated the potential for this approach by determining whether bisphosphonates interact with osteoblasts in vitro. The effects of pamidronate (P), clodronate (C), and etidronate (E) in solution and when coated onto HA were investigated. P inhibited protein and collagen syntheses potently when in solution, but not after being bound to HA. When bound to HA, both P and C increased DNA, protein and collagen syntheses of osteoblasts and may encourage the osseointegration of implants. The pharmacological effects of the bisphosphonates studied altered dramatically after binding to HA. This must be fully investigated before this approach to prolonging prostheses stability can be evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Report. Department of health research and development directorate (1995) p. 7.

  2. E. Ingham and J. Fisher, Proc. Instn. Mech. Eng. 214 (2000) 21.

    Google Scholar 

  3. P. M. Boonekamp, L. J. A Van Der Wee-Pals, M. M. L. Van Wijk-Van Lennep, C. Wil Thesing and O. L. M. Bijvoet, Bone Miner. 1 (1986) 27-39.

    Google Scholar 

  4. A. Carano, S. L. Teitelbaum, J. D Konsek, P. H. Schlesinger and H. C. Blair. J. Clin. Invest. 85 (1990) 456-461.

    Google Scholar 

  5. M. G. Cecchini, R. Felix, H. Fleisch and P. H. Cooper, J. Bone Miner. Res. 2(2) (1987) 135-142.

    Google Scholar 

  6. D. E Hughes, M. Mian, D. F. Guilland-Cumming and R. G. G. Russell, Drugs Exptl. Clin. Res. 17(2) (1991) 109-114.

    Google Scholar 

  7. S. M. Horowitz, S. A. Algan and M. A. Purdon, J. Biomed. Mater. Research 31 (1996) 91-96.

    Google Scholar 

  8. C. W. G. M. Lowik, G. Van Der Pluijm, L. J. A. Van Der Wee-Pals, H. Bloys Van Treslong-De Groot and O. L. M. Bijvoet, J. Bone Miner. Res. 3(2) (1988) 185.

    Google Scholar 

  9. M. J. Rogers, D. J. Watts, R. Graham and R. Russell, Amer. Cancer Soc. (1997).

  10. G. A. Rodan, Annu. Rev. Pharmacol. Toxicol. 38 (1998) 375-88.

    Google Scholar 

  11. S. Adami and N. Zamberlan, Drug Safety 14 (1996) 158.

    Google Scholar 

  12. H. Fleisch, “Bisphosphonates in Bone Disease. From the Laboratory to the Patient” (Parthenon Publishing, 1995).

  13. M. Yoshinari, Y. Oda, H. Ueki and S. Yokose, Biomaterials 22 (2001) 709-715

    Google Scholar 

  14. H. Fleisch, Bone 8(1) (1987) 23.

    Google Scholar 

  15. A. Goziotis, B. Sukhu, M. Torontali, M. Dowhaniuk and H. C. Tenenbaum, ibid. 16(4) (1995) 317S-327S.

    Google Scholar 

  16. K. Igarashi, M. Hirafuji, H. Adachi, H. Shinoda and H. Mitani, Prostogalndins, Leukotrienes and Essential Fatty Acids 56(2) (1997) 121-125.

    Google Scholar 

  17. M. A. Khokher and P. Dandona, Metabolism 38(2) (1989) 184-187.

    Google Scholar 

  18. M. Tsuchimoto, Y. Azuma, O. Higuchi, I. Sugimoto, N. Hirata, M. Kiyoki and I. Yamamoto, Jpn. J. Pharmacol. 66 (1994) 25-33.

    Google Scholar 

  19. R. Macnair, R. Wilkinson, C. Macdonald, I. Goldie, D. Jones and M. H. Grant, Cells Mater. 6 (1996) 71.

    Google Scholar 

  20. R. Macnair, H. Rodgers, C. Macdonald, A. Wykman, I. Goldie and M. H. Grant, J. Mat. Sci.: Mat. Med. 8 (1997) 105.

    Google Scholar 

  21. C. Morrison, R. Macnair, C. Macdonald, A. Wykman, I. Goldie and M. H. Grant, Biomaterials 16 (1995) 987.

    Google Scholar 

  22. P. J. Hissin and R. Hilf, Anal. Biochem. 74 (1976) 214.

    Google Scholar 

  23. O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, J. Biol. Chem. 193 (1951) 265.

    Google Scholar 

  24. Q. Shi, J. D. S. Gaylor, R. Cousins, J. Plevris, P. C. Hayes and M. H. Grant, Artif. Organs. 22 (1998) 1023.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. H. Grant.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ganguli, A., Henderson, C., Grant, M.H. et al. The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts. Journal of Materials Science: Materials in Medicine 13, 923–931 (2002). https://doi.org/10.1023/A:1019892109411

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1019892109411

Keywords

Navigation